EMJ GOLD: Pharma news, views and analysis
by EMJ
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm.Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
Episodes
-
S12 E04: Richard Shotton on behaviour, bias and better pharma marketing
In this episode, Isabel sits down with Richard Shotton, founder of Astroten and author of Hacking the Human Mind, to explore how behavioral science can help the pharmaceutical industry communicate more effectively and influence meaningful change. In the show, Richard explains why understanding…
more -
S12 E03: Rafal Kaminski on epilepsy, innovation and equity
This content has been funded by Angelini Pharma. In this episode, Isabel sits down with Rafal Kaminski, Chief Scientific Officer, Angelini Pharma, to explore how new science is reshaping brain health and what that means for patients. In the episode, Rafal reflects on his path into neuroscience…
more -
Deep Dive 3: Sex Differences in Alzheimer's Disease: Tailored Prevention Approaches
In the final episode, the focus turns to prevention. Rachel Buckley examines whether Alzheimer's strategies should be sex-specific, the timing of interventions, and how lifestyle factors like physical activity contribute to brain resilience. The discussion also highlights gaps in research and the...
-
Deep Dive 2: Sex Differences in Alzheimer's Disease: Reproductive Health
This episode explores how reproductive ageing and biological sex influence Alzheimer's disease risk. Rachel Buckley discusses menopause, hormonal changes, genetic factors such as the X chromosome, and emerging evidence showing differences in tau accumulation between women and men. Timestamps:...
-
S12 E02: Rethinking multiple sclerosis care: The future of MS
In Part 3, Hideki Garren, Roche, shares a hopeful vision for slowing, stopping and ultimately preventing multiple sclerosis. Guest bio Hideki Garren is Senior Vice President and Global Head of Clinical Development, Neurology, Roche, appointed in September 2024. He brings extensive leadership...
-
S12 E02: Rethinking multiple sclerosis care: Challenging old frameworks
In Part 2, Hideki Garren, Roche, discusses the challenge of measuring MS progression and the importance of better data, imaging and patient insight. Guest bio Hideki Garren is Senior Vice President and Global Head of Clinical Development, Neurology, Roche, appointed in September 2024. He brings...
-
S12 E02: Rethinking multiple sclerosis care: From curiosity to care
This week, Isabel sits down with Hideki Garren, Senior Vice President and Global Head of Clinical Development, Neurology, Roche, to explore how our understanding of multiple sclerosis is changing and what that means for patients. *]:pointer-events-auto...
-
Precision Cardiology for Women: How to Prevent
In the final episode of this series, Leslie Cho focuses on prevention. From lifestyle interventions and pregnancy-related risk to menopause, brain health, and cholesterol management, she shares practical strategies clinicians can use today to improve long-term cardiovascular outcomes for women.
-
Precision Cardiology for Women: What the Data Really Says
Why does cardiovascular data so often fail women? In Part 2, Leslie Cho unpacks how trial design, symptom bias, and underdiagnosis of microvascular disease distort care for women, and what the evidence actually tells us about diagnosis, imaging, and treatment.
-
S12 E01: The 2026 pharma forecast: Unknowns and personal goals
In Part 2 of the 2026 pharma forecast, the guests discuss the biggest unknowns for the year ahead and share a personal goal they're working towards in 2026. Speaker bios Dheepa Chari Vice President and Head of Global Scientific Communications, GSK Dheepa leads strategy and execution across...
-
S12 E01: The 2026 pharma forecast: Opportunities and threats
As 2026 gets underway, healthcare and life sciences face a year of both promise and pressure, with investment, innovation and equity all in sharp focus. In Part 1 of this year's pharma forecast, four leaders explore where real opportunity lies, from health investment to personalisation and…
more -
S11 E05: Pharma's year in review 2025
This week, Isabel brings together three expert voices for an end-of-year round-up, reflecting on the moments that shaped healthcare and life sciences in 2025. Joined by Jonathan Sackier, Chairman, Medical Advisory Board, EMJ, Hanna Svanbäck, Executive Director for Neuroscience, Eli Lilly, and...
-
S11 E04: The gender health divide: Driving change
In Part 3, Carol Pitcher-Towner, Alnylam Pharmaceuticals, explores how the pharmaceutical industry can become part of the solution. She highlights why leadership diversity matters, how trial design still excludes too many women and why embedding sex- and gender-aware science from day one could...
-
S11 E04: The gender health divide: Bias in practice
In Part 2, Carol Pitcher-Towner, Alnylam Pharmaceuticals, breaks down the systemic forces driving inequity, from diagnostic bias to the lack of women in key specialties like cardiology, and explains how historical clinical trial exclusion continues to skew the science. Discover why representation...
-
S11 E04: The gender health divide: Tracing the gap
This week, Isabel sits down with Carol Pitcher-Towner, Senior Vice President and Head of Development Programmes, Alnylam Pharmaceuticals, to unpack the gender inequities that continue to tarnish modern healthcare. Together, they explore the realities behind unequal outcomes and the steps needed…
more -
E11 E03: Shaping the future of Alzheimer's care: The future of care
In Part 3, Hanna Svanbäck discusses the future of Alzheimer's care over the next five to 10 years, how trial design could be improved and reveals her opinion on the most exciting healthcare innovation on the horizon. Speaker bio Hanna Svanbäck is the Executive Director for Neuroscience, Eli…
more -
E11 E03: Shaping the future of Alzheimer's care: Research and discoveries
In Part 2, Hanna Svanbäck discusses the latest and most significant innovations in Alzheimer's care. She also considers whether healthcare systems are prepared for the anticipated surge in cases, and shares some positive news about prevention. Speaker bio Hanna Svanbäck is the Executive Director...
-
S11 E03: Shaping the future of Alzheimer's care: Building a career in neuroscience
This week, Isabel sits down with Hanna Svanbäck, Executive Director for Neuroscience, Eli Lilly, for an insightful discussion on the evolving landscape of Alzheimer's research. Together, they explore the latest breakthroughs, the challenges ahead and the strategies shaping the future of treatment...
-
S11 E02: Transforming critical care through innovation: Future of advanced life support
In Part 3 of the conversation, Giuseppe Savoja, Western Europe Senior Business Director, Cardiac Surgery Business at Medtronic, talks about his outlook for the future of his field, his views on how the industry and clinicians can collaborate more effectively and the healthcare changes he is most...
-
S11 E02: Transforming critical care through innovation: ECMO: Then and now
In Part 2 of the conversation, Giuseppe Savoja, Western Europe Senior Business Director, Cardiac Surgery Business, Medtronic, shares how ECMO has transformed over the decades and explores how clinicians and industry can work together to support the most vulnerable patients in intensive care.…
more -
S11 E02: Transforming critical care through innovation: Building a career in MedTech
This week, Isabel is joined by Giuseppe Savoja, Western Europe Senior Business Director, Cardiac Surgery Business at Medtronic, for a deep-dive into the evolution and future of ECMO, innovation in critical care and the realities of leading in the MedTech space. In Part 1 of the interview…
more -
S11 E01: Men's role in women's health: Repairing the gap
In Part 2 of this conversation, Robert Stewart, CEO, Theramex, explains how wider society can improve outcomes for women and reflects on the impact of decades of neglect in the field. Speaker bio Robert Stewart is CEO of Theramex, a global pharma company committed to supporting women's health...
-
S11 E01: Men's role in women's health: Raising awareness and breaking taboos
The EMJ GOLD podcast returns. To launch the series, Isabel is joined by Robert Stewart, CEO, Theramex – a global pharmaceutical company solely dedicated to women's health. In Part 1 of this discussion, they unpack what inspired Rob's professional focus in this area and the role men can play in...
-
S10 E10: Season 10's insights, inspiration and 'aha' moments
Tune in as Isabel and Jade analyse the standout moments from EMJ GOLD's guests this season, uncovering the challenges and opportunities shaping today's pharmaceutical industry. From self-advocacy at work and the future of personalised medicine to disease awareness, market access and making your...
-
S10 E09: Bayer's Dr Joana Reis on the promise of AI in breast cancer
How can industry close the screening gap in breast cancer? Find out in this episode, where Dr Joana Reis, Medical Affairs Breast Lead, Radiology, Bayer, explores some of the most significant challenges and opportunities in imaging today. Together, Jade and Joana discuss her initial interest in a...
-
S10 E08: AbbVie's Dr Daejin Adiboye on community and compassion in cancer care
Tune in as Dr Daejin Adiboye, Vice President, Therapeutic Area Head, Solid Tumor Oncology, AbbVie, explores both the evolution of cancer care and his leadership style over the last two decades. Together, Daejin and Jade discuss the lessons from his time in the clinic that shaped who he is today,...
-
S10 E07: Chiesi's Shish Patel on COPD, the climate and improving care
What is the environmental impact of respiratory illness? Find out in this episode of the EMJ GOLD podcast, where Shish Patel, Medical Director, Chiesi UK, joins Isabel to discuss the rising burden of COPD and the impact of respiratory care on the planet. Together, the two explore the diagnostic…
more -
S10 E06: GSK's Matt Mortimer-Ryan on behaviour-led pharma marketing
In this week's episode of the EMJ GOLD Podcast, Matt Mortimer Ryan, Senior Global Marketing Manager, Vaccines, GSK, shares his perspective on how understanding patients' emotional drivers can unlock more impactful, insight-led disease awareness campaigns. Matt joins Isabel to discuss what true...
-
S10 E05: Analysing key trends in medical affairs in 2025
In this special edition of the EMJ GOLD podcast, Isabel and Jade dive into the latest insights from recent contributors and EMJ's own data to uncover what healthcare professionals really want from medical affairs. They explore the growing challenges of engaging HCPs, question whether there's a…
more -
E10 E04: Pfizer's Richard Maughan on the future of access in the UK
This week, the team is joined by Richard Maughan, Senior Director and Head of UK Policy and Public Affairs, Pfizer, to explore how the UK is shaping access to medicine today, and what needs to change in the future. From healthy ageing to the economic cost of respiratory infections, they dive into...
-
E10 E03: BMS' Anita Gandhi on a decade of change in hematology
This National Blood Week, the team sit down with Anita Gandhi, Vice President, Translational Development, BMS, to explore the last decade of innovation in hematology and what lies ahead for the space. Together, Anita and Jade discuss Anita's route into the pharmaceutical industry, the current…
more -
S10 E02: Yacin Marzouki on disrupting the traditional omnichannel model
This week on the podcast, the team are joined by omnichannel engagement expert Yacin Marzouki, who shares his strategies on how to make omnichannel work for both pharmaceutical companies and healthcare professionals. Together, Yacin and Jade sit down in the studio to explore what it takes to...
-
S10 E01: GSK's Dheepa Chari on the evolving sphere of scientific communication
The EMJ GOLD podcast is back for a new season! In the first episode of season 10, the team are joined by Dheepa Chari, Vice President and Head of Global Scientific Communications, GSK, to discuss the past, present and future of scientific communications. Together, Dheepa and Isabel explore her...
-
Season 9 highlights: GOLD Medal Moments
Season 10 is on the horizon, but before we release our first episode, why not tune in to some of Isabel and Jade's favourite moments from season 9? From leadership insights from top CEOs to navigating setbacks in R&D, there's plenty to discover in this season's batch of GOLD Medal Moments. As…
more -
S09 E10: Galen's Dr Dennise Broderick on why kindness isn't a weakness in business
Join Isabel and Jade as they wrap up Season 9 of the podcast with special guest Dennise Broderick, President and Managing Director, Galen Pharma. In this episode, Jade and Dennise discuss her move from academia to the pharmaceutical industry, her lifelong ambition to be a leader and how she...
-
S09 E09: Boehringer's Christoph von der Goltz on setbacks and success in R&D
How can pharmaceutical companies best navigate setbacks in drug development to deliver breakthroughs in R&D? Find out in this week's episode, where Isabel and Jade share an interview with Christoph von der Goltz, Global Head of Medicine Central Nervous System and Emerging Areas, Boehringer...
-
S09 E08: HBA STAR Rebecca Vermeulen on purpose, passion and patients
Join Isabel and Jade this week as they delve into lessons in leadership and patient centricity with Rebecca Vermeulen, recipient of the Healthcare Businesswomen's Association (HBA) STAR award for 2025. Rebecca shares her journey from pharmacist to industry leader, discussing her approach to...
-
S09 E07: DeepHealth's Naiara Martínez Cabrera on AI's role in radiology
Join Isabel and Jade as they uncover how AI is shaking up the radiology space and beyond with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth. Together, Naiara and Jade explore what first drew the marketing leader to the healthcare sector, why radiology in particular has…
more -
S09 E06: Boston Scientific's Angelo Auricchio on what's next for heart health
This week, join Isabel and Jade as they explore what's on the horizon for cardiac care, focusing on the revolutionary impact of remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific. He and Isabel discuss Angelo's recent career change into the...
-
S09 E05: The HBA's Mary Stutts on tackling bias for better women's health
Join Isabel and Jade as they explore the persistent misunderstandings of women's health in modern medicine with Mary Stutts, CEO of the Healthcare Businesswomen's Association. In this episode, Mary unpacks the key findings of the HBA's latest report, which exposes critical gaps in doctors'...
-
S09 E04: Does interactivity boost memory, recall and retention?
Why do we forget? Join Isabel and Jade as they explore the science behind memory, recall and retention, and uncover why interactive content could be the key to making information stick. In this episode, discover how interactivity enhances learning, helps HCPs recognise the value of new therapies...
-
S09 E03: J&J's Martin Price on World Cancer Day 2025 – Part 2
Join Isabel and Jade for part two of their World Cancer Day special for 2025, where guest Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson, uncovers more of his insights into the oncology space. In this instalment, Martin shares his thoughts...
-
S09 E02: J&J's Martin Price on World Cancer Day
Join Isabel and Jade as they present a special World Cancer Day 2025 edition of the podcast. They are joined by Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson. In this first instalment of the conversation, Martin and Jade discuss this…
more -
S09 E01: Lundbeck's Charl van Zyl on a new era in neurology
The EMJ GOLD podcast is back for a new season! In the first episode of Season 9, the team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders, making this the 'decade of the brain', and how industry can do more…
more -
The 2025 pharma forecast
Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year's predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead. The...
-
Bonus episode: Pharma review of the year 2024
As 2024 comes to a close, it's time to look back on a year in the pharmaceutical industry. In this final episode of the year, Isabel and Jade are joined by three former guest to reflect on the pivotal moments that defined the past 12 months. They are joined by Jennifer Schranz from Ipsen, Martina...
-
S08 E10: Bayer's Dr Cecilia Caetano on making space for menopause
In this final episode of the season, Isabel discusses how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Head, Global Medical Affairs, Women's Health, Bayer. Menopause affects over 50% of the world's population, but its symptoms and...
-
Season 8 highlights: GOLD Medal Moments
Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the last couple of months? From an insight into why Gen Z might be turning their sails towards the pharmaceutical industry, to a call for a better understanding of HIV...
-
S08 E09: World AMR Awareness Week with Orcason Medical's Elias Revonta
In this episode of the EMJ GOLD podcast, Jade and Isabel explore one of the most urgent global health issues: antimicrobial resistance (AMR). As part of World AMR Awareness Week, they are highlighting this year's theme 'Educate. Advocate. Act now'. Joining the conversation is Elias Revonta…
more -
S08 E08: Alfasigma's Patrick Oliver on the company's new chapter in the UK
In this episode, Isabel welcomes Patrick Oliver, General Manager for the UK and Ireland at Alfasigma, to explore the company's exciting entry into the UK market and the evolving landscape of healthcare in the country. In the conversation, Patrick brings his wealth of industry experience to share...
About this show
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm.Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
Hosted by
EMJ